Invasive mould infections are a major cause of infectious mortality in highly immunosuppressed patients. Incidence in this high risk group is 10-20% with a death rate in excess of 50%. Most invasive moulds are Aspergillus spp. We present a case of a 74-year-old woman with acute lymphoblastic leukaemia who developed a rare disseminated mould infection with Fusarium solani during induction chemotherapy. We present the case story and discuss the pathogenesis, clinical characteristics and treatment of invasive fusariosis.
|Bidragets oversatte titel||Disseminated fusariosis in a patient with acute lymphoblastic leukaemia|
|Tidsskrift||Ugeskrift for laeger|
|Status||Udgivet - sep. 2008|